Media

Oncos Therapeutics granted US and EU Orphan Drug Designation

Aerocrine announce that NICE guidelines support the FeNO measurement in diagnosis and management of asthma

Cerenis Reports Top-Line Phase II Results for its HDL Mimetic CER-001

AEROCRINE AB strengthens its financial position by a rights issue of approximately SEK 445 million

Aerocrine Interim report January – September 2014

Nordic Nanovector and Affibody collaborate on advanced radio-immunotherapies program for Multiple Myeloma

GLIONOVA RECEIVES SEK 5 MILLION GRANT FROM SWEDISH INNOVATION AGENCY VINNOVA

WILSON THERAPEUTICS ANNOUNCES START OF PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF WTX101 IN NEWLY DIAGNOSED WILSON DISEASE PATIENTS

GLIONOVA THERAPEUTICS SECURES SEK 42 MILLION ($5.7 MILLION) CO-LEAD BY HEALTHCAP AND NOVO TO TAKE NOVEL THERAPY FOR GLIOBLASTOMA INTO CLINIC

Ultragenyx Reports Third Quarter 2014 Financial Results and Corporate Update